News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
298,908 Results
Type
Article (8351)
Company Profile (109)
Press Release (290448)
Section
Business (105446)
Career Advice (631)
Deals (18371)
Drug Delivery (19)
Drug Development (31805)
Employer Resources (42)
FDA (4718)
Job Trends (5802)
News (160162)
Policy (10173)
Tag
Academia (527)
Africa (281)
Alabama (25)
Alliances (22394)
Alzheimer's disease (372)
Approvals (4688)
Arizona (53)
Asia (16734)
Australia (3014)
Bankruptcy (122)
Best Places to Work (4291)
Biotechnology (99)
C2C Services and Suppliers (28495)
California (955)
Canada (467)
Cancer (157)
Career advice (550)
Cell therapy (53)
China (42)
Clinical research (25122)
Collaboration (54)
Colorado (20)
Compensation (32)
Connecticut (34)
COVID-19 (618)
Cystic fibrosis (24)
Data (122)
Diabetes (17)
Diagnostics (2356)
Earnings (44493)
Employer resources (42)
Europe (35939)
Events (52111)
Executive appointments (94)
FDA (4783)
Florida (102)
Funding (58)
Gene therapy (21)
GLP-1 (147)
Government (665)
Healthcare (5859)
Hotbed/Location (218763)
Idaho (29)
Illinois (110)
Indiana (62)
Infectious disease (621)
Inflammatory bowel disease (43)
Interviews (67)
IPO (9158)
Job creations (1587)
Job search strategy (511)
Kansas (33)
Layoffs (115)
Legal (2773)
Lung cancer (24)
Maine (32)
Manufacturing (29)
Maryland (127)
Massachusetts (793)
Medical device (4019)
Medtech (4020)
Mergers & acquisitions (9190)
Metabolic disorders (60)
Michigan (85)
Minnesota (116)
Neuroscience (418)
New Jersey (265)
New York (308)
NextGen Class of 2024 (2232)
Non-profit (910)
North Carolina (313)
Northern California (440)
Obesity (41)
Ohio (41)
Opinion (59)
Patents (22)
Pennsylvania (265)
People (32426)
Phase I (8487)
Phase II (11340)
Phase III (7635)
Pipeline (79)
Policy (22)
Postmarket research (751)
Preclinical (3507)
Press Release (72)
Rare diseases (44)
Real estate (2859)
Regulatory (6946)
Research institute (530)
Resumes & cover letters (86)
South America (425)
Southern California (385)
Startups (1680)
Texas (94)
United States (4095)
Utah (22)
Vaccines (48)
Washington State (180)
Weight loss (24)
Date
Today (39)
Last 7 days (318)
Last 30 days (997)
Last 365 days (18067)
2024 (12626)
2023 (19655)
2022 (26037)
2021 (27325)
2020 (24230)
2019 (17579)
2018 (13597)
2017 (14003)
2016 (13026)
2015 (16257)
2014 (12821)
2013 (10431)
2012 (11334)
2011 (12050)
2010 (11620)
298,908 Results for "generex biotechnology corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
Business
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced results for the first quarter ended 2024 and provided a corporate update.
May 29, 2024
·
18 min read
Press Releases
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
July 30, 2024
·
1 min read
Business
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
August 12, 2024
·
10 min read
Business
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and organ manufacturing, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.
April 4, 2024
·
22 min read
Business
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, reported financial results for the quarter ended March 31, 2024.
May 7, 2024
·
15 min read
BioForest
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL.
May 29, 2024
·
1 min read
Business
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2023.
February 22, 2024
·
23 min read
Business
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - April 4, 2024
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and organ manufacturing, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.
April 4, 2024
·
22 min read
Business
Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical
Generex Biotechnology Corporation announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc.
July 26, 2021
·
4 min read
1 of 29,891
Next
